PubMed:25230104
Annnotations
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-83 | Sentence | denotes | Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. |
T2 | 84-95 | Sentence | denotes | UNLABELLED: |
T3 | 96-212 | Sentence | denotes | Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory disorders of the gastrointestinal tract. |
T4 | 213-368 | Sentence | denotes | In IBD, protein serological biomarkers could be relevant tools for assessing disease activity, performing early-stage diagnosis and managing the treatment. |
T5 | 369-587 | Sentence | denotes | Using the interleukin-10 knockout (IL-10(-/-)) mouse, a model that develops a time-dependent IBD-like disorder that predominates in the colon; we performed longitudinal studies of circulating protein biomarkers in IBD. |
T6 | 588-806 | Sentence | denotes | Circulating protein profiles in serum samples collected from 30-, 93-, to 135-day-old IL-10(-/-) mice were investigated using two-dimensional differential gel electrophoresis and MALDI-TOF/TOF tandem mass spectrometry. |
T7 | 807-1033 | Sentence | denotes | A total of 15 different proteins were identified and confirmed by ELISA and Western blot to be differentially accumulated in serum samples from mid- to late-stage IL-10(-/-) mice compared to early non-inflamed IL-10(-/-) mice. |
T8 | 1034-1305 | Sentence | denotes | The use of another model of colitis and an extra-intestinal inflammation model validated this biomarker panel and demonstrated that comprised some global inflammatory markers, some intestinal inflammation-specific markers and some chronic intestinal inflammation markers. |
T9 | 1306-1450 | Sentence | denotes | Statistical analyses using misclassification error rate charts validated the use of these identified proteins as powerful biomarkers of colitis. |
T10 | 1451-1618 | Sentence | denotes | Unlike standard biomarker screening studies, our analyses identified a panel of proteins that allowed the definition of protein signatures that reflect colitis status. |
T11 | 1619-1643 | Sentence | denotes | BIOLOGICAL SIGNIFICANCE: |
T12 | 1644-1768 | Sentence | denotes | Crohn's disease (CD) and ulcerative colitis (UC) are the most common inflammatory bowel diseases (IBDs) occurring in humans. |
T13 | 1769-1870 | Sentence | denotes | The major current diagnosis tool is colonoscopy, which is invasive and could lead to false diagnosis. |
T14 | 1871-2006 | Sentence | denotes | The emergence of serological biomarkers enables the use of new diagnosis tools such as protein signatures for IBD diagnosis/management. |
T15 | 2007-2178 | Sentence | denotes | Using 2D-DIGE coupled to mass spectrometry, our longitudinal study in a mouse model of colitis identified a signature of protein biomarkers for specific stages of disease. |
T1 | 0-83 | Sentence | denotes | Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. |
T2 | 84-95 | Sentence | denotes | UNLABELLED: |
T3 | 96-212 | Sentence | denotes | Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory disorders of the gastrointestinal tract. |
T4 | 213-368 | Sentence | denotes | In IBD, protein serological biomarkers could be relevant tools for assessing disease activity, performing early-stage diagnosis and managing the treatment. |
T5 | 369-587 | Sentence | denotes | Using the interleukin-10 knockout (IL-10(-/-)) mouse, a model that develops a time-dependent IBD-like disorder that predominates in the colon; we performed longitudinal studies of circulating protein biomarkers in IBD. |
T6 | 588-806 | Sentence | denotes | Circulating protein profiles in serum samples collected from 30-, 93-, to 135-day-old IL-10(-/-) mice were investigated using two-dimensional differential gel electrophoresis and MALDI-TOF/TOF tandem mass spectrometry. |
T7 | 807-1033 | Sentence | denotes | A total of 15 different proteins were identified and confirmed by ELISA and Western blot to be differentially accumulated in serum samples from mid- to late-stage IL-10(-/-) mice compared to early non-inflamed IL-10(-/-) mice. |
T8 | 1034-1305 | Sentence | denotes | The use of another model of colitis and an extra-intestinal inflammation model validated this biomarker panel and demonstrated that comprised some global inflammatory markers, some intestinal inflammation-specific markers and some chronic intestinal inflammation markers. |
T9 | 1306-1450 | Sentence | denotes | Statistical analyses using misclassification error rate charts validated the use of these identified proteins as powerful biomarkers of colitis. |
T10 | 1451-1618 | Sentence | denotes | Unlike standard biomarker screening studies, our analyses identified a panel of proteins that allowed the definition of protein signatures that reflect colitis status. |
T11 | 1619-1643 | Sentence | denotes | BIOLOGICAL SIGNIFICANCE: |
T12 | 1644-1768 | Sentence | denotes | Crohn's disease (CD) and ulcerative colitis (UC) are the most common inflammatory bowel diseases (IBDs) occurring in humans. |
T13 | 1769-1870 | Sentence | denotes | The major current diagnosis tool is colonoscopy, which is invasive and could lead to false diagnosis. |
T14 | 1871-2006 | Sentence | denotes | The emergence of serological biomarkers enables the use of new diagnosis tools such as protein signatures for IBD diagnosis/management. |
T15 | 2007-2178 | Sentence | denotes | Using 2D-DIGE coupled to mass spectrometry, our longitudinal study in a mouse model of colitis identified a signature of protein biomarkers for specific stages of disease. |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 505-510 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colon |
T2 | 1083-1093 | http://purl.obolibrary.org/obo/MAT_0000043 | denotes | intestinal |
T3 | 1215-1225 | http://purl.obolibrary.org/obo/MAT_0000043 | denotes | intestinal |
T4 | 1273-1283 | http://purl.obolibrary.org/obo/MAT_0000043 | denotes | intestinal |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-83 | Sentence | denotes | Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. |
T2 | 84-95 | Sentence | denotes | UNLABELLED: |
T3 | 96-212 | Sentence | denotes | Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory disorders of the gastrointestinal tract. |
T4 | 213-368 | Sentence | denotes | In IBD, protein serological biomarkers could be relevant tools for assessing disease activity, performing early-stage diagnosis and managing the treatment. |
T5 | 369-587 | Sentence | denotes | Using the interleukin-10 knockout (IL-10(-/-)) mouse, a model that develops a time-dependent IBD-like disorder that predominates in the colon; we performed longitudinal studies of circulating protein biomarkers in IBD. |
T6 | 588-806 | Sentence | denotes | Circulating protein profiles in serum samples collected from 30-, 93-, to 135-day-old IL-10(-/-) mice were investigated using two-dimensional differential gel electrophoresis and MALDI-TOF/TOF tandem mass spectrometry. |
T7 | 807-1033 | Sentence | denotes | A total of 15 different proteins were identified and confirmed by ELISA and Western blot to be differentially accumulated in serum samples from mid- to late-stage IL-10(-/-) mice compared to early non-inflamed IL-10(-/-) mice. |
T8 | 1034-1305 | Sentence | denotes | The use of another model of colitis and an extra-intestinal inflammation model validated this biomarker panel and demonstrated that comprised some global inflammatory markers, some intestinal inflammation-specific markers and some chronic intestinal inflammation markers. |
T9 | 1306-1450 | Sentence | denotes | Statistical analyses using misclassification error rate charts validated the use of these identified proteins as powerful biomarkers of colitis. |
T10 | 1451-1618 | Sentence | denotes | Unlike standard biomarker screening studies, our analyses identified a panel of proteins that allowed the definition of protein signatures that reflect colitis status. |
T11 | 1619-1643 | Sentence | denotes | BIOLOGICAL SIGNIFICANCE: |
T12 | 1644-1768 | Sentence | denotes | Crohn's disease (CD) and ulcerative colitis (UC) are the most common inflammatory bowel diseases (IBDs) occurring in humans. |
T13 | 1769-1870 | Sentence | denotes | The major current diagnosis tool is colonoscopy, which is invasive and could lead to false diagnosis. |
T14 | 1871-2006 | Sentence | denotes | The emergence of serological biomarkers enables the use of new diagnosis tools such as protein signatures for IBD diagnosis/management. |
T15 | 2007-2178 | Sentence | denotes | Using 2D-DIGE coupled to mass spectrometry, our longitudinal study in a mouse model of colitis identified a signature of protein biomarkers for specific stages of disease. |
T1 | 0-83 | Sentence | denotes | Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. |
T2 | 84-95 | Sentence | denotes | UNLABELLED: |
T3 | 96-212 | Sentence | denotes | Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory disorders of the gastrointestinal tract. |
T4 | 213-368 | Sentence | denotes | In IBD, protein serological biomarkers could be relevant tools for assessing disease activity, performing early-stage diagnosis and managing the treatment. |
T5 | 369-587 | Sentence | denotes | Using the interleukin-10 knockout (IL-10(-/-)) mouse, a model that develops a time-dependent IBD-like disorder that predominates in the colon; we performed longitudinal studies of circulating protein biomarkers in IBD. |
T6 | 588-806 | Sentence | denotes | Circulating protein profiles in serum samples collected from 30-, 93-, to 135-day-old IL-10(-/-) mice were investigated using two-dimensional differential gel electrophoresis and MALDI-TOF/TOF tandem mass spectrometry. |
T7 | 807-1033 | Sentence | denotes | A total of 15 different proteins were identified and confirmed by ELISA and Western blot to be differentially accumulated in serum samples from mid- to late-stage IL-10(-/-) mice compared to early non-inflamed IL-10(-/-) mice. |
T8 | 1034-1305 | Sentence | denotes | The use of another model of colitis and an extra-intestinal inflammation model validated this biomarker panel and demonstrated that comprised some global inflammatory markers, some intestinal inflammation-specific markers and some chronic intestinal inflammation markers. |
T9 | 1306-1450 | Sentence | denotes | Statistical analyses using misclassification error rate charts validated the use of these identified proteins as powerful biomarkers of colitis. |
T10 | 1451-1618 | Sentence | denotes | Unlike standard biomarker screening studies, our analyses identified a panel of proteins that allowed the definition of protein signatures that reflect colitis status. |
T11 | 1619-1643 | Sentence | denotes | BIOLOGICAL SIGNIFICANCE: |
T12 | 1644-1768 | Sentence | denotes | Crohn's disease (CD) and ulcerative colitis (UC) are the most common inflammatory bowel diseases (IBDs) occurring in humans. |
T13 | 1769-1870 | Sentence | denotes | The major current diagnosis tool is colonoscopy, which is invasive and could lead to false diagnosis. |
T14 | 1871-2006 | Sentence | denotes | The emergence of serological biomarkers enables the use of new diagnosis tools such as protein signatures for IBD diagnosis/management. |
T15 | 2007-2178 | Sentence | denotes | Using 2D-DIGE coupled to mass spectrometry, our longitudinal study in a mouse model of colitis identified a signature of protein biomarkers for specific stages of disease. |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 172-211 | HP_0011024 | denotes | disorders of the gastrointestinal tract |
T2 | 172-211 | HP_0002012 | denotes | disorders of the gastrointestinal tract |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 56-82 | Disease | denotes | inflammatory bowel disease | http://purl.obolibrary.org/obo/MONDO_0005265 |
T2 | 96-123 | Disease | denotes | Inflammatory bowel diseases | http://purl.obolibrary.org/obo/MONDO_0005265 |
T3 | 125-129 | Disease | denotes | IBDs | http://purl.obolibrary.org/obo/MONDO_0005265 |
T4 | 159-181 | Disease | denotes | inflammatory disorders | http://purl.obolibrary.org/obo/MONDO_0021166 |
T5 | 216-219 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T7 | 462-465 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T9 | 583-586 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T11 | 1062-1069 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
T12 | 1083-1106 | Disease | denotes | intestinal inflammation | http://purl.obolibrary.org/obo/MONDO_0002269 |
T13 | 1215-1238 | Disease | denotes | intestinal inflammation | http://purl.obolibrary.org/obo/MONDO_0002269 |
T14 | 1273-1296 | Disease | denotes | intestinal inflammation | http://purl.obolibrary.org/obo/MONDO_0002269 |
T15 | 1442-1449 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
T16 | 1603-1610 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
T17 | 1644-1659 | Disease | denotes | Crohn's disease | http://purl.obolibrary.org/obo/MONDO_0005011 |
T18 | 1661-1663 | Disease | denotes | CD | http://purl.obolibrary.org/obo/MONDO_0005011 |
T19 | 1669-1687 | Disease | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/MONDO_0005101|http://purl.obolibrary.org/obo/MONDO_0009960 |
T21 | 1689-1691 | Disease | denotes | UC | http://purl.obolibrary.org/obo/MONDO_0005101 |
T22 | 1713-1740 | Disease | denotes | inflammatory bowel diseases | http://purl.obolibrary.org/obo/MONDO_0005265 |
T23 | 1742-1746 | Disease | denotes | IBDs | http://purl.obolibrary.org/obo/MONDO_0005265 |
T24 | 1981-1984 | Disease | denotes | IBD | http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265 |
T26 | 2094-2101 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 416-421 | OrganismTaxon | denotes | mouse | 10088|10090 |
T3 | 685-689 | OrganismTaxon | denotes | mice | 10088 |
T4 | 981-985 | OrganismTaxon | denotes | mice | 10088 |
T5 | 1028-1032 | OrganismTaxon | denotes | mice | 10088 |
T6 | 2079-2084 | OrganismTaxon | denotes | mouse | 10088|10090 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 505-510 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T2 | 1083-1093 | Body_part | denotes | intestinal | http://purl.obolibrary.org/obo/MAT_0000043 |
T3 | 1215-1225 | Body_part | denotes | intestinal | http://purl.obolibrary.org/obo/MAT_0000043 |
T4 | 1273-1283 | Body_part | denotes | intestinal | http://purl.obolibrary.org/obo/MAT_0000043 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 69-74 | Body_part | denotes | bowel | http://purl.obolibrary.org/obo/UBERON_0000160 |
T2 | 109-114 | Body_part | denotes | bowel | http://purl.obolibrary.org/obo/UBERON_0000160 |
T3 | 189-211 | Body_part | denotes | gastrointestinal tract | http://purl.obolibrary.org/obo/UBERON_0005409 |
T4 | 505-510 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T5 | 1726-1731 | Body_part | denotes | bowel | http://purl.obolibrary.org/obo/UBERON_0000160 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 56-82 | Phenotype | denotes | inflammatory bowel disease | HP:0002037 |
T2 | 96-123 | Phenotype | denotes | Inflammatory bowel diseases | HP:0002037 |
T3 | 125-129 | Phenotype | denotes | IBDs | HP:0002037 |
T4 | 1062-1069 | Phenotype | denotes | colitis | HP:0002583 |
T5 | 1083-1106 | Phenotype | denotes | intestinal inflammation | HP:4000055 |
T6 | 1215-1238 | Phenotype | denotes | intestinal inflammation | HP:4000055 |
T7 | 1273-1296 | Phenotype | denotes | intestinal inflammation | HP:4000055 |
T8 | 1442-1449 | Phenotype | denotes | colitis | HP:0002583 |
T9 | 1603-1610 | Phenotype | denotes | colitis | HP:0002583 |
T10 | 1644-1659 | Phenotype | denotes | Crohn's disease | HP:0100280 |
T11 | 1661-1663 | Phenotype | denotes | CD | HP:0100280 |
T12 | 1669-1687 | Phenotype | denotes | ulcerative colitis | HP:0100279 |
T13 | 1689-1691 | Phenotype | denotes | UC | HP:0100279 |
T14 | 1713-1740 | Phenotype | denotes | inflammatory bowel diseases | HP:0002037 |
T15 | 1742-1746 | Phenotype | denotes | IBDs | HP:0002037 |
T16 | 2094-2101 | Phenotype | denotes | colitis | HP:0002583 |